Immune cells known as myeloid-derived suppressor cells (MDSCs) keep other immune cells in check. They have been found to accumulate in individuals with cancer, where they are thought to contribute to tumor development. Researchers have now identified a molecular pathway that enhances the immunosuppressive functions of tumor-associated mouse and human MDSCs.